Homocysteine metabolism in families from southern Italy with neural tube defects: Role of genetic and nutritional determinants

Prenatal Diagnosis

Volumn 26, Issue 1, 2006, Pages 1-5

  Grandone, Elvira ^a   Corrao, Anna Maria ^b   Colaizzo, Donatella ^a   Vecchione, Gennaro ^a   Di Girgenti, Caterina ^b   Paladini, Dario ^c   Sardella, Luigi ^d   Pellegrino, Michele ^a   Zelante, Leopoldo ^a   Martinelli, Pasquale ^c   Margaglione, Maurizio ^a,e  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b ARNAS Civico di Cristina Ascoli   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

^e UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Homocysteine plasma levels; Neural tube defects; Polymorphisms

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); AMINO ACID; CYANOCOBALAMIN; DNA; FOLIC ACID; HOMOCYSTEINE;

ADULT; ALLELE; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; BIRTH DEFECT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY STUDY; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; ITALY; MALE; NEURAL TUBE DEFECT; NUTRITION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMOCYSTEINE; HUMANS; INFANT; ITALY; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; NEURAL TUBE DEFECTS; NUTRITIONAL STATUS;

EID: 31944431893     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1359     Document Type: Article

References (28)

1. Botto LD, Yang Q. 2000. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151(9): 862-877.
2. Daly LE, Kirke PN, Molloy AM, Weir DG, Scott JM. 1995. Folate levels and neural tube defects: implications for prevention. JAMA 274: 1698-1702.
3. de Franchis R, Buoninconti A, Mandato C, et al. 1998. The C 677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy. J Med Genet 35(12): 1009-1013.
4. Eurocat Working Group. 1991. Prevalence of neural tube defects in 20 regions of Europe and the impact of prenatal diagnosis 1980-86. J Epidemiol Community Health 45: 52-58.
5. Frosst P, Blom HJ, Milos R, et al. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113.
6. Isotalo PA, Wells GA, Donnelly JG 2000. Neonatal and Fetal Methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet 67: 986-990.
7. Kang S, Wong PWK, Norusis M 1987. Homocysteinemia due to folate deficiency. Metabolism 36: 458-462.
8. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM 1993. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 86: 703-708.
9. Kirke PN, Mills JL, Molloy AM, et al. 2004. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study. BMJ 328(7455): 1535-1536.
10. Koch MC, Stegmann K, Ziegler A, Schroter B, Ermert A. 1998. Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population. Eur J Pediatr 157(6): 487-492.
11. Linnebank M, Hornberger A, Junker R, Nowak-Goettl U, Harms E, Koch HG 2001. High prevalence of the I278T mutation of the human cystathionine b- synthase detected by a novel screening application. Thromb Haemost 85(6): 986-988.
12. Magera MJ, Lacey JM, Casetta B, Rinaldo P. 1999. Method for the determination of total homocysteine in plasma and urine by stable isotope dilution and electrospray tandem mass spectrometry. Clin Chem 45(9): 1517-1522.
13. Margaglione M, Brancaccio V, Giuliani N, et al. 1998. Increased risk for venous thrombosis in carriers of the FII G > A 20210 gene variant. Ann Intern Med 129: 89-93.
14. Morrison K, Papapetrou C, Hol FA, et al. 1998. Susceptibility to spina bifida; an association study of five candidate genes. Ann Hum Genet 62(Pt 5): 379-396.
15. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 2: 131-137.
16. Papapetrou C, Lynch SA, Burn J, Edwards YH. 1996. Methylenetetrahydrofolate reductase and neural tube defects. Lancet 348(9019): 58.
17. Parle-McDermott A, Mills JL, Kirke PN, et al. 2003. Analysis of the MTHFR 1298A → C and 677C → T polymorphisms as risk factors for neural tube defects. J Hum Genet 48(4): 190-193.
18. Ramsbottom D, Scott JM, Molloy A, et al. 1997. Are common mutations of cystathionine beta-synthase involved in the aetiology of neural tube defects? Clin Genet 51(1): 39-42.
19. Shields DC, Kirke PN, Mills JL, et al. 1999. The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 64(4): 1045-1055.
20. Speer MC, Worley G, Mackey JF, Melvin E, Oakes WJ, George TM. 1997. The thermolabile variant of methylenetetrahydrofolate reductase (MTHFR) is not a major risk factor for neural tube defect in American Caucasians. The NTD Collaborative Group. Neurogenetics 1(2): 149-150.
21. Steegers-Theunissen RP, Boers GH, Blom HJ, et al. 1995. Neural tube defects and elevated homocysteine levels in amniotic fluid. Am J Obstet Gynecol 172(5): 1436-1441.
22. van der Put NMJ, Eskes TKAB, Blom HJ. 1997. Is the common 677C > T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. Q J Med 90: 111-115.
23. van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJM. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346: 1070-1071.
24. van der Put NM, Gabreels F, Stevens EMB, et al. 1998. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural tube defects? Am J Hum Genet 62: 1044-1051.
25. Vilaseca MA, Moyano D, Ferrer I, Artuch R. 1997. Total homocysteine in pediatric patients. Clin Chem 43: 690-692.
26. Volcik KA, Blanton SH, Tyerman GH, et al. 2000. Methylenetetrahydrofolate reductase and spima bifida: evaluation of level of defect and maternal genotypic risk in Hispanics. Am J Med Genet 95: 21-27.
27. Wenstrom KD, Johanning GL, Owen J, et al. 2000. Amniotic fluid homocysteine levels, 5,10-methylenetetrahydrofolate reductase genotypes, and neural tube closure sites. Am J Med Genet 90: 6-11.
28. Zhao R, Zhu H, Dao J, Li Z. 2000. Study on genotypes of cystathionine beta-synthase in neural tube defects. Wei Sheng Yan Jiu 29(1): 50-51.